Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Lineage Cell Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lineage Cell Therapeutics Inc. June 9, 202698.7%
-
Lineage Cell Therapeutics Inc. June 26, 202598.8%
-
Lineage Cell Therapeutics Inc. June 11, 202498.4%
-
Lineage Cell Therapeutics Inc. September 6, 202383.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 22, 2024 | Lineage Cell Therapeutics Inc. | Open-market purchase | +40,000 | $0.57 | $22,800 |
Questions about Michael H. Mulroy
What boards is Michael H. Mulroy on?
Michael H. Mulroy sits on the board of Lineage Cell Therapeutics Inc.
How long has Michael H. Mulroy served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.